Intrinsic Value of S&P & Nasdaq Contact Us

Cronos Group Inc. CRON NASDAQ

NASDAQ Global Market • Healthcare • Drug Manufacturers - Specialty & Generic • CA • USD

SharesGrow Score
50/100
2/7 Pass
SharesGrow Intrinsic Value
$7.81
+203.9%
Analyst Price Target
$2.30
-10.5%

Stock Statistics — CRON

Cronos Group Inc. (CRON) has a market capitalization of $988.47M and trades at $2.57. The 52-week range is 1.6-3.43.

Key metrics include a trailing Price-to-Earnings (P/E) ratio of -104.9, Earnings Per Share (EPS) of $-0.02, annual revenue of $193.36M.

The stock has a beta of 1.21, operates in the Healthcare sector.

Trading Data
Current Price$2.57
52-Week Range1.6-3.43
Volume1.03M
Avg Volume (30D)1.16M
Market Cap$988.47M
Beta (1Y)1.21
Company
IPO Date2018-02-27
Employees459
CEOMichael Ryan Gorenstein
CountryCA
ExchangeNASDAQ Global Market
CurrencyUSD
ISINCA22717L1013
CUSIP22717L101
Income (Latest Year)
Revenue$193.36M
Gross Profit$62.76M
EBITDA$-15M
Operating Income$-2.93M
Net Income$-9.45M
EPS$-0.02
EPS Diluted$-0.02
Shares Outstanding$385.31M
Balance Sheet (Latest Year)
Total Assets$1.2B
Current Assets$944.09M
Cash & ST Investments$831.79M
Total Liabilities$54.18M
Total Debt$1.51M
Net Debt$-790.29M
Total Equity$1.14B
Debt / Equity0.00
Valuation Ratios
P/E Ratio-104.9
P/S Ratio5.11
P/B Ratio0.86
Contact Us
🎓
SharesGrow Academy
Learn how to calculate Intrinsic Value and find undervalued stocks.
Weekly live sessions
Send us a message